David Cavalla
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Journal: Critical care (London, England)
Published: April 04, 2023
Drug repurposing: Known knowns to unknown unknowns - Network analysis of the repurposome.
Journal: Drug discovery today
Published: February 14, 2023
Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory Depression.
Journal: Anesthesiology
Published: July 22, 2022
Drug repurposing: progress, challenges and recommendations.
Journal: Nature reviews. Drug discovery
Published: October 13, 2018
Using human experience to identify drug repurposing opportunities: theory and practice.
Journal: British journal of clinical pharmacology
Published: October 08, 2018
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
Journal: Human molecular genetics
Published: February 21, 2018
Tianeptine prevents respiratory depression without affecting analgesic effect of opiates in conscious rats.
Journal: European journal of pharmacology
Published: January 15, 2015
Predictive methods in drug repurposing: gold mine or just a bigger haystack?
Journal: Drug discovery today
Published: November 01, 2012
Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups.
Journal: Drug discovery today
Published: August 02, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026